US Stock MarketDetailed Quotes

ORIC Oric Pharmaceuticals

Watchlist
  • 9.480
  • +0.070+0.74%
Close Nov 4 16:00 ET
  • 9.480
  • 0.0000.00%
Post 16:37 ET
668.74MMarket Cap-5386P/E (TTM)

Oric Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-21.19%-25.63M
-46.34%-30.19M
-14.03%-85.69M
-58.33%-24.27M
-1.68%-19.65M
-18.95%-21.15M
9.20%-20.63M
-26.20%-75.14M
5.86%-15.33M
-59.12%-19.32M
Net income from continuing operations
-39.31%-31.96M
-4.45%-25.01M
-12.99%-100.7M
-35.89%-28.33M
-2.61%-25.48M
-13.10%-22.94M
-3.39%-23.95M
-13.22%-89.12M
8.45%-20.85M
-34.75%-24.83M
Operating gains losses
----
----
-45.00%22K
--13K
--0
----
----
1,900.00%40K
----
----
Depreciation and amortization
5.02%272K
3.16%261K
6.83%1.03M
6.48%263K
16.29%257K
4.86%259K
0.80%253K
7.69%966K
7.86%247K
1.84%221K
Change In working capital
426.48%3.37M
-2,726.05%-8.17M
1,200.67%4.9M
-27.09%1.98M
53.66%3.63M
40.54%-1.03M
108.19%311K
-110.93%-445K
4.21%2.72M
1.07%2.37M
-Change in prepaid assets
-105.69%-434K
-318.40%-2.41M
57.28%1.62M
-21.30%1.01M
-114.85%-277K
86.61%-211K
305.78%1.1M
-9.81%1.03M
867.42%1.28M
165.29%1.87M
-Change in payables and accrued expense
563.41%3.8M
-627.02%-5.76M
322.24%3.28M
-32.20%979K
682.20%3.91M
-418.99%-820K
75.71%-792K
-150.32%-1.48M
-41.75%1.44M
-69.46%500K
Cash from discontinued investing activities
Operating cash flow
-21.19%-25.63M
-46.34%-30.19M
-14.03%-85.69M
-58.33%-24.27M
-1.68%-19.65M
-18.95%-21.15M
9.20%-20.63M
-26.20%-75.14M
5.86%-15.33M
-59.12%-19.32M
Investing cash flow
Cash flow from continuing investing activities
194.65%18.28M
-584.18%-61.87M
60.27%-43.4M
-25.93%20.96M
-8,342.48%-57.83M
58.20%-19.31M
114.09%12.78M
-168.95%-109.25M
7,962.68%28.3M
-101.95%-685K
Net PPE purchase and sale
17.78%-333K
29.68%-218K
59.14%-849K
80.14%-57K
80.80%-77K
39.28%-405K
57.12%-310K
-121.30%-2.08M
26.22%-287K
-72.10%-401K
Net investment purchase and sale
198.44%18.61M
-571.04%-61.65M
60.29%-42.55M
-26.47%21.02M
-20,235.92%-57.75M
58.48%-18.91M
114.55%13.09M
-167.24%-107.17M
3,763.11%28.59M
-100.80%-284K
Cash from discontinued investing activities
Investing cash flow
194.65%18.28M
-584.18%-61.87M
60.27%-43.4M
-25.93%20.96M
-8,342.48%-57.83M
58.20%-19.31M
114.09%12.78M
-168.95%-109.25M
7,962.68%28.3M
-101.95%-685K
Financing cash flow
Cash flow from continuing financing activities
-99.04%816K
125.03M
239.58%85.66M
-98.17%453K
3,000.00%31K
20,423.86%85.17M
0
-48.66%25.23M
2,949.57%24.79M
-100.00%1K
Net common stock issuance
--0
--125M
240.00%85M
-99.10%226K
---226K
--85M
--0
-50.00%25M
--25M
--0
Proceeds from stock option exercised by employees
104.00%816K
--198K
41.83%885K
136.46%454K
3,000.00%31K
-3.61%400K
--0
-36.71%624K
-76.38%192K
-98.99%1K
Net other financing activities
--0
---168K
43.11%-227K
----
----
----
----
78.46%-399K
----
----
Cash from discontinued financing activities
Financing cash flow
-99.04%816K
--125.03M
239.58%85.66M
-98.17%453K
3,000.00%31K
20,423.86%85.17M
--0
-48.66%25.23M
2,949.57%24.79M
-100.00%1K
Net cash flow
Beginning cash position
-4.38%56.85M
-64.53%23.88M
-70.28%67.31M
-9.53%26.73M
110.25%104.17M
-47.43%59.46M
-70.28%67.31M
188.70%226.47M
-87.77%29.54M
-70.87%49.55M
Current changes in cash
-114.60%-6.53M
520.08%32.98M
72.71%-43.43M
-107.56%-2.85M
-287.15%-77.45M
170.35%44.72M
93.08%-7.85M
-207.52%-159.17M
349.76%37.76M
-127.97%-20M
End cash Position
-51.69%50.32M
-4.38%56.85M
-64.53%23.88M
-64.53%23.88M
-9.53%26.73M
110.25%104.17M
-47.43%59.46M
-70.28%67.31M
-70.28%67.31M
-87.77%29.54M
Free cash flow
-20.45%-25.96M
-45.21%-30.4M
-12.06%-86.54M
-55.78%-24.33M
-0.01%-19.72M
-16.85%-21.55M
10.68%-20.94M
-27.68%-77.22M
6.34%-15.62M
-59.36%-19.72M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -21.19%-25.63M-46.34%-30.19M-14.03%-85.69M-58.33%-24.27M-1.68%-19.65M-18.95%-21.15M9.20%-20.63M-26.20%-75.14M5.86%-15.33M-59.12%-19.32M
Net income from continuing operations -39.31%-31.96M-4.45%-25.01M-12.99%-100.7M-35.89%-28.33M-2.61%-25.48M-13.10%-22.94M-3.39%-23.95M-13.22%-89.12M8.45%-20.85M-34.75%-24.83M
Operating gains losses ---------45.00%22K--13K--0--------1,900.00%40K--------
Depreciation and amortization 5.02%272K3.16%261K6.83%1.03M6.48%263K16.29%257K4.86%259K0.80%253K7.69%966K7.86%247K1.84%221K
Change In working capital 426.48%3.37M-2,726.05%-8.17M1,200.67%4.9M-27.09%1.98M53.66%3.63M40.54%-1.03M108.19%311K-110.93%-445K4.21%2.72M1.07%2.37M
-Change in prepaid assets -105.69%-434K-318.40%-2.41M57.28%1.62M-21.30%1.01M-114.85%-277K86.61%-211K305.78%1.1M-9.81%1.03M867.42%1.28M165.29%1.87M
-Change in payables and accrued expense 563.41%3.8M-627.02%-5.76M322.24%3.28M-32.20%979K682.20%3.91M-418.99%-820K75.71%-792K-150.32%-1.48M-41.75%1.44M-69.46%500K
Cash from discontinued investing activities
Operating cash flow -21.19%-25.63M-46.34%-30.19M-14.03%-85.69M-58.33%-24.27M-1.68%-19.65M-18.95%-21.15M9.20%-20.63M-26.20%-75.14M5.86%-15.33M-59.12%-19.32M
Investing cash flow
Cash flow from continuing investing activities 194.65%18.28M-584.18%-61.87M60.27%-43.4M-25.93%20.96M-8,342.48%-57.83M58.20%-19.31M114.09%12.78M-168.95%-109.25M7,962.68%28.3M-101.95%-685K
Net PPE purchase and sale 17.78%-333K29.68%-218K59.14%-849K80.14%-57K80.80%-77K39.28%-405K57.12%-310K-121.30%-2.08M26.22%-287K-72.10%-401K
Net investment purchase and sale 198.44%18.61M-571.04%-61.65M60.29%-42.55M-26.47%21.02M-20,235.92%-57.75M58.48%-18.91M114.55%13.09M-167.24%-107.17M3,763.11%28.59M-100.80%-284K
Cash from discontinued investing activities
Investing cash flow 194.65%18.28M-584.18%-61.87M60.27%-43.4M-25.93%20.96M-8,342.48%-57.83M58.20%-19.31M114.09%12.78M-168.95%-109.25M7,962.68%28.3M-101.95%-685K
Financing cash flow
Cash flow from continuing financing activities -99.04%816K125.03M239.58%85.66M-98.17%453K3,000.00%31K20,423.86%85.17M0-48.66%25.23M2,949.57%24.79M-100.00%1K
Net common stock issuance --0--125M240.00%85M-99.10%226K---226K--85M--0-50.00%25M--25M--0
Proceeds from stock option exercised by employees 104.00%816K--198K41.83%885K136.46%454K3,000.00%31K-3.61%400K--0-36.71%624K-76.38%192K-98.99%1K
Net other financing activities --0---168K43.11%-227K----------------78.46%-399K--------
Cash from discontinued financing activities
Financing cash flow -99.04%816K--125.03M239.58%85.66M-98.17%453K3,000.00%31K20,423.86%85.17M--0-48.66%25.23M2,949.57%24.79M-100.00%1K
Net cash flow
Beginning cash position -4.38%56.85M-64.53%23.88M-70.28%67.31M-9.53%26.73M110.25%104.17M-47.43%59.46M-70.28%67.31M188.70%226.47M-87.77%29.54M-70.87%49.55M
Current changes in cash -114.60%-6.53M520.08%32.98M72.71%-43.43M-107.56%-2.85M-287.15%-77.45M170.35%44.72M93.08%-7.85M-207.52%-159.17M349.76%37.76M-127.97%-20M
End cash Position -51.69%50.32M-4.38%56.85M-64.53%23.88M-64.53%23.88M-9.53%26.73M110.25%104.17M-47.43%59.46M-70.28%67.31M-70.28%67.31M-87.77%29.54M
Free cash flow -20.45%-25.96M-45.21%-30.4M-12.06%-86.54M-55.78%-24.33M-0.01%-19.72M-16.85%-21.55M10.68%-20.94M-27.68%-77.22M6.34%-15.62M-59.36%-19.72M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data